Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print July 19, 2006, doi:10.1212/01.wnl.0000227890.87398.c1)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 67, Number 3, August 8, 2006
Right arrow Italian Translation
Right arrow All Versions of this Article:
01.wnl.0000227890.87398.c1v1
67/3/394    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blekher, T.
Right arrow Articles by Foroud, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blekher, T.
Right arrow Articles by Foroud, T.
Related Collections
Right arrow Huntington's disease
Right arrow Ocular motility
Right arrow Clinical trials Methodology/study design
NEUROLOGY 2006;67:394-399
© 2006 American Academy of Neurology

Saccades in presymptomatic and early stages of Huntington disease

T. Blekher, PhD, S. A. Johnson, PhD, J. Marshall, BS, K. White, MS, S. Hui, PhD, M. Weaver, MS, J. Gray, BS, R. Yee, MD, J. C. Stout, PhD, X. Beristain, MD, J. Wojcieszek, MD and T. Foroud, PhD

From the Departments of Ophthalmology (T.B., R.Y.), Medical and Molecular Genetics (J.M., K.W., M.W., J.G., T.F.), Medicine, Division of Biostatistics (S.H.), and Neurology (X.B., J.W.), Indiana University School of Medicine, Indianapolis; and Department of Psychological and Brain Science (S.A.J., J.C.S.), Indiana University, Bloomington.

Address correspondence and reprint requests to Dr. Tanya Blekher, Indiana University School of Medicine, Department of Ophthalmology, 702 Rotary Circle, Indianapolis, IN 46202-5251; e-mail: tblekher{at}iupui.edu

Objective: To evaluate quantitative measures of eye movements as possible biomarkers in prediagnostic and early stages of Huntington disease (HD).

Methods: The study sample (n = 215) included individuals both at risk and recently diagnosed with HD. All participants completed a uniform clinical evaluation which included administration of the Unified Huntington’s Disease Rating Scale (UHDRS) by a movement disorder neurologist and molecular testing to determine HD gene status. A high resolution, video-based eye tracking system was employed to quantify measures of eye movement (error rates, latencies, SD of latencies, velocities, and accuracies) during a computerized battery of saccadic and steady fixation tasks.

Results: Prediagnostic HD gene carriers and individuals with early HD demonstrated three types of significant abnormalities while performing memory guided and anti-saccade tasks: increased error rate, increased saccade latency, and increased variability of saccade latency. The eye movement abnormalities increased with advancing motor signs of HD.

Conclusions: Abnormalities in eye movement measures are a sensitive biomarker in the prediagnostic and early stages of Huntington disease (HD). These measures may be more sensitive to prediagnostic changes in HD than the currently employed neurologic motor assessment.

Editorial, see page 376

See also page 485

This article was previously published in electronic format as an Expedited E-Pub at www.neurology.org.

Supported by NIH grants R01 NS042659, N01-NS-3-2357, and MO1 RR-00750 and an unrestricted grant from Research to Prevent Blindness, Inc., to the Department of Ophthalmology, Indiana University School of Medicine.

Disclosure: The authors report no conflicts of interest.

Received January 17, 2006.

Accepted in final form April 18, 2006.




This article has been cited by other articles:


Home page
 J. Neurophysiol.Home page
K. A. Ford and S. Everling
Neural Activity in Primate Caudate Nucleus Associated With Pro- and Antisaccades
J Neurophysiol, October 1, 2009; 102(4): 2334 - 2341.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
J. Brandt, A. B. Inscore, J. Ward, B. Shpritz, A. Rosenblatt, R. L. Margolis, and C. A. Ross
Neuropsychological Deficits in Huntington's Disease Gene Carriers and Correlates of Early "Conversion"
J Neuropsychiatry Clin Neurosci, November 1, 2008; 20(4): 466 - 472.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. C. Fahey, P. D. Cremer, S. T. Aw, L. Millist, M. J. Todd, O. B. White, M. Halmagyi, L. A. Corben, V. Collins, A. J. Churchyard, et al.
Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia
Brain, April 1, 2008; 131(4): 1035 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Kloppel, B. Draganski, C. V. Golding, C. Chu, Z. Nagy, P. A. Cook, S. L. Hicks, C. Kennard, D. C. Alexander, G. J. M. Parker, et al.
White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease
Brain, January 1, 2008; 131(1): 196 - 204.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. M. Biglan and M. Halmagyi
The eyes as a window into disease prevention
Neurology, August 8, 2006; 67(3): 376 - 377.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.